|
文献名
|
提交时间
|
查询结果
|
回复时间
|
|
Myocardial deletion of transcription factor CHF1/Hey2 results inaltered myocyte action potential and mild conduction system expansion but does not alter conduction syetem function or promote spontaneous arrhythmias
|
2017-09-12 20:29:38
|
已发送至邮箱
|
2017-09-13 11:18:43
|
|
Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome
|
2017-09-12 20:29:05
|
已发送至邮箱
|
2017-09-13 11:15:57
|
|
SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
|
2017-09-12 20:28:24
|
已发送至邮箱
|
2017-09-13 11:13:44
|
|
Complex Brugada syndrome inheri-tance in a family harbouring compound SCN5A and CACNA1C muta⁃tions
|
2017-09-12 20:27:48
|
已发送至邮箱
|
2017-09-13 13:39:19
|
|
About Brugada syndrome and its prevalence
|
2017-09-12 20:26:00
|
已发送至邮箱
|
2017-09-13 11:10:19
|
|
Schisantherin B ameliorates Aβ1-42-induced cognitive decline via restoration of GLT-1 in a mouse model of Alzheimer's disease
|
2017-09-12 10:52:10
|
已发送至邮箱
|
2017-09-12 15:06:23
|
|
N-methyl-D-aspartate receptors mediate epilepsy-induced axonal impairment and tau phosphorylation via activating glycogen synthase kinase-3β and cyclin-dependent kinase 5.
|
2017-09-12 10:41:47
|
已发送至邮箱
|
2017-09-14 08:54:24
|
|
Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors
|
2017-09-12 10:40:58
|
暂时未查到相关文献
|
2017-09-13 16:50:33
|
|
Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice
|
2017-09-12 10:39:41
|
已发送至邮箱
|
2017-09-12 15:40:11
|
|
Class III malocclusion treated with distalization of the mandibular dentition with miniscrew anchorage: A 2-year follow-up.
|
2017-09-11 22:08:58
|
已发送至邮箱
|
2017-09-12 14:58:18
|